JP2024531446A5 - - Google Patents
Info
- Publication number
- JP2024531446A5 JP2024531446A5 JP2024510734A JP2024510734A JP2024531446A5 JP 2024531446 A5 JP2024531446 A5 JP 2024531446A5 JP 2024510734 A JP2024510734 A JP 2024510734A JP 2024510734 A JP2024510734 A JP 2024510734A JP 2024531446 A5 JP2024531446 A5 JP 2024531446A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cancer
- immune cell
- immune
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21192853 | 2021-08-24 | ||
| EP21192853.6 | 2021-08-24 | ||
| PCT/EP2022/073462 WO2023025788A1 (en) | 2021-08-24 | 2022-08-23 | Il-10 expressing cells for enhanced cancer immunotherapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531446A JP2024531446A (ja) | 2024-08-29 |
| JP2024531446A5 true JP2024531446A5 (https=) | 2025-08-13 |
Family
ID=77499640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510734A Pending JP2024531446A (ja) | 2021-08-24 | 2022-08-23 | 癌免疫療法の増強のためのｉｌ－１０発現細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240424096A1 (https=) |
| EP (1) | EP4392549A1 (https=) |
| JP (1) | JP2024531446A (https=) |
| KR (1) | KR20240049813A (https=) |
| CN (1) | CN118043450A (https=) |
| AU (1) | AU2022334870A1 (https=) |
| CA (1) | CA3228536A1 (https=) |
| MX (1) | MX2024002436A (https=) |
| WO (1) | WO2023025788A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023129929A1 (en) * | 2021-12-30 | 2023-07-06 | Tr1X, Inc. | Cd4+ t cells expressing il-10 and chimeric antigen receptors and uses thereof |
| CN121100177A (zh) * | 2023-04-03 | 2025-12-09 | 香港北恒生物科技有限公司 | 靶向IL10和Claudin 18.2的工程化细胞及其用途 |
| WO2025148750A1 (zh) * | 2024-01-08 | 2025-07-17 | 上药生物治疗（香港）有限公司 | 膜表达il-10及其用途 |
| WO2026061386A1 (zh) * | 2024-09-18 | 2026-03-26 | 上药生物治疗（香港）有限公司 | Gpc3 car及其应用 |
| CN119331826B (zh) * | 2024-12-18 | 2025-08-05 | 智在汉青生物科技(浙江)有限公司 | 用于增强细胞免疫疗法的表达非分泌型il-10的免疫细胞、制备方法及用途 |
| CN119823288A (zh) * | 2025-03-19 | 2025-04-15 | 中山大学 | 一种靶向alppl2及her2蛋白的car-t细胞及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| PH12013501201A1 (en) | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| US9987308B2 (en) | 2011-03-23 | 2018-06-05 | Fred Hutchinson Cancer Research Center | Method and compositions for cellular immunotherapy |
| US20160361415A1 (en) * | 2015-05-28 | 2016-12-15 | Armo Biosciences, Inc. | Methods of Using Interleukin-10 for Treating Diseases and Disorders |
| AU2018367452B2 (en) * | 2017-11-14 | 2024-06-13 | Memorial Sloan-Kettering Cancer Center | IL-36 secreting immunoresponsive cells and uses thereof |
-
2022
- 2022-08-23 WO PCT/EP2022/073462 patent/WO2023025788A1/en not_active Ceased
- 2022-08-23 KR KR1020247007741A patent/KR20240049813A/ko active Pending
- 2022-08-23 CA CA3228536A patent/CA3228536A1/en active Pending
- 2022-08-23 AU AU2022334870A patent/AU2022334870A1/en active Pending
- 2022-08-23 US US18/684,249 patent/US20240424096A1/en active Pending
- 2022-08-23 CN CN202280064538.1A patent/CN118043450A/zh active Pending
- 2022-08-23 MX MX2024002436A patent/MX2024002436A/es unknown
- 2022-08-23 EP EP22776870.2A patent/EP4392549A1/en active Pending
- 2022-08-23 JP JP2024510734A patent/JP2024531446A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024531446A5 (https=) | ||
| Fenis et al. | New immune cell engagers for cancer immunotherapy | |
| Yeku et al. | Adoptive T-cell therapy for solid tumors | |
| JP7428663B2 (ja) | いくつかの多重抗原の標的用の逆ユニバーサルキメラ抗原受容体を発現する免疫細胞ならびにその製造方法ならびに癌、感染症および自己免疫疾患を治療するためのその使用 | |
| JP7487112B2 (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| ES2681948T3 (es) | Células de acoplamiento para inmunoterapia | |
| ES2833162T3 (es) | Receptor de antígeno quimérico y su uso | |
| JP2021530243A5 (https=) | ||
| CN113227379A (zh) | 多功能多靶向嵌合抗原受体（car）系统及其使用方法 | |
| JP2022545439A5 (https=) | ||
| US20210095029A1 (en) | Compositions and methods for treating cancer | |
| JP2023512452A (ja) | Ｂｃｍａ指向性細胞免疫療法組成物および方法 | |
| JP7812549B2 (ja) | 人工免疫監視キメラ抗原受容体（ａｉ－ｃａｒ）及びそれを発現する細胞 | |
| WO2015197016A1 (zh) | 时空可调性抑制病理性靶细胞的系统 | |
| Li et al. | Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments | |
| JP2022553292A5 (https=) | ||
| Hayashi et al. | A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells | |
| JP2023540023A5 (https=) | ||
| JP2023512657A5 (https=) | ||
| RU2024105406A (ru) | Клетки, экспрессирующие il-10, для улучшенной иммунотерапии рака | |
| WO2024148107A2 (en) | Epcam-cd3 epsilon bispecific antibodies | |
| JP2025506515A5 (https=) | ||
| Li et al. | Genetically modified T-cells affinity to tumor cells-development of adoptive T-cell immunotherapy | |
| KR102896643B1 (ko) | 자연살해세포-특이적 키메릭항원수용체 및 이의 용도 |